Global Postpartum Hemorrhage Treatment Devices Market Is Segmented by Type (by Uterine Balloon Tamponade Market, Foley Catheters Market, Condom Catheters Market, by Uniject Prefilled Injection System, by Nonpneumatic Antishock Garment) & by Geography.
Key Findings The postpartum hemorrhage (PPH) treatment device market size is poised to expand to $1155 million by 2025, at a CAGR of 6.57% between 2017 and 2025. The base year considered for the postpartum hemorrhage treatment device market report is 2016 and the forecast period is from 2017 to 2025. Rise in the awareness in developing countries among people for postpartum treatment, growing occurrence of postpartum hemorrhage and increase in the government educational initiatives and training about women health are the main factors driving the global postpartum hemorrhage treatment device market.
Download free sample of this report with TOC: https://www.inkwoodresearch.com/reports/global-postpartum-hemorrhage-treatment-devices-market-forecast-2017-2025/
Market Insights The global postpartum hemorrhage treatment device market is segmented on the basis of type and by geography. The global postpartum hemorrhage market by type is further bifurcated into uterine balloon tamponade market, uniject prefilled injection system and nonpneumatic antishock garment. The uterine balloon tamponade market type is further segmented into global foley catheters market, global condom catheters market and global others market. The segment of geography in global postpartum hemorrhage market is classified into North America, Europe, Asia-Pacific and rest of the world. Rise in the awareness in people in the developing countries for postpartum treatment, growth in the occurrence of postpartum hemorrhage, conception in postpartum hemorrhage, risk factor and increase in the government initiatives and training about women health are leading the growth of the global postpartum hemorrhage market.
Regional Insights The postpartum hemorrhage treatment device market in North America is expected to hold the largest share by 2025. The increase in the occurrence of PPH across North America, growth in the alertness among patients coupled with advanced healthcare service providers, improved hospital delivery rates, as well as viable accessibility of treatment devices are some of the factors driving excellent demand from the North American PPH treatment devices market. After the US and Canada, UK and Germany are estimated to be the developing markets for the postpartum hemorrhage treatment device. The mentioned countries are expected to adopt most of the technological developments, compared to other geographic regions.
Competitive Insights Major players in the postpartum hemorrhage treatment device market are 3rd Stone Design Inc, Bactiguard AB, C.R.BardInc, Cook Medical Inc, DavolInc, Teleflex Incorporated, Utah Medical Products Inc, Becton Dickinson and Company, GE Healthcare, and Program for Appropriate Technology in Health (PATH), ZoexNiasg, and Inpress Technologies.
Explore All Healthcare Industry Research Reports of Inkwood Research https://www.inkwoodresearch.com/reports/category/healthcare/